OTCs NCPA
Latest
GLP-1 access expands with launch of oral Ozempic
Novo Nordisk is launching a pill form of Ozempic, offering a new option for type 2 diabetes and positioning pharmacies at the forefront of access, adherence, and the growing GLP-1 demand.
FMI welcomes House passage of Farm Bill
“FMI looks forward to working with policymakers on both sides of the aisle to ensure final enactment of a Farm Bill that meets the needs of the entire food industry and the consumers we serve.”
GoodRx expands offerings to now include Ozempic Pill for Type 2 diabetes patients
Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per month.
PCMA endorses Secretary Kennedy’s call for nationwide adoption of real time pharmacy benefit technology
"PCMA strongly supports real-time benefit tools, which not only provide visibility for patients but ensure providers consider the cost associated with therapeutically-equivalent medications."